류마티스 관절염 환자에서 심장 조직 검사로 확진된 아밀로이드단백 A 심장 아밀로이드증
Systemic Amyloid Protein a Amyloidosis Involving the Heart in a Patient with Rheumatoid Arthritis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Amyloidosis can be identified by the deposition of amyloid fibrils in biopsy specimens from multiple organs, including the heart,kidney, skin, and bowel. Systemic amyloid protein A amyloidosis (AA amyloidosis) is commonly associated with chronic inflammatorydiseases or chronic infectious conditions. Cardiac involvement in AA amyloidosis is found in < 1% of reported cases. Here, we report a case of cardiac AA amyloidosis confirmed by heart biopsy in a 54-year-old-female with a medical history of rheumatoidarthritis and stage 4 chronic kidney disease due to renal amyloidosis. She had suffered from progressive aggravation ofdyspnea for 2 years. Infiltrative disease involving the heart was suspected by echocardiography, and the patient was diagnosed withAA amyloidosis involving the heart by cardiac biopsy. This is a rare case of cardiac involvement in a patient with systemic AA amyloidosisassociated with rheumatoid arthritis.
Abstract
Amyloidosis can be identified by the deposition of amyloid fibrils in biopsy specimens from multiple organs, including the heart,kidney, skin, and bowel. Systemic amyloid protein A amyloidosis (AA amyloidosis) is commonly associated with chronic inflammatorydiseases or chronic infectious conditions. Cardiac involvement in AA amyloidosis is found in < 1% of reported cases. Here, we report a case of cardiac AA amyloidosis confirmed by heart biopsy in a 54-year-old-female with a medical history of rheumatoidarthritis and stage 4 chronic kidney disease due to renal amyloidosis. She had suffered from progressive aggravation ofdyspnea for 2 years. Infiltrative disease involving the heart was suspected by echocardiography, and the patient was diagnosed withAA amyloidosis involving the heart by cardiac biopsy. This is a rare case of cardiac involvement in a patient with systemic AA amyloidosisassociated with rheumatoid arthritis.
참고문헌 (11)
- Leung N, "How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing", Blood, 120, pp.3206~3213 (2012)
- Lachmann HJ, "Natural history and outcome in systemic AA amyloidosis", N Engl J Med, 356, pp.2361~2371 (2007)
- Gillmore JD, "Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein", Lancet, 358, pp.24~29 (2001)
- Merlini G, "Molecular mechanisms of amyloidosis", N Engl J Med, 349, pp.583~596 (2003)
- Falk RH, "Diagnosis and management of the cardiac amyloidoses", Circulation, 112, pp.2047~2060 (2005)
- Obici L, "Amyloidosis in autoinflammatory syndromes", Autoimmun Rev, 12, pp.14~17 (2012)
- Pinney JH, "Amyloidosis", Ann Clin Biochem, 49(3), pp.229~241 (2012)
- Ha SJ, "A case of systemic amyloidosis following ankylosing spondylitis associated with congestive heart failure", J Am Soc Echocardiogr, 22, pp.542.e5~542.e7 (2009)
- Kapoor P, "Cardiac amyloidosis: a practical approach to diagnosis and management", Am J Med, 124, pp.1006~1015 (2011)
- Wada Y, "Cardiac AA amyloidosis in a patient with rheumatoid arthritis and systemic sclerosis: the therapeutic potential of biological reagents", Scand J Rheumatol, 40, pp.402~404 (2011)
- Selvanayagam JB, "Evaluation and management of the cardiac amyloidosis", J Am Coll Cardiol, 50, pp.2101~2110 (2007)
